Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Almer, G; Frascione, D; Pali-Schoell, I; Vonach, C; Lukschal, A; Stremitzer, C; Diesner, SC; Jensen-Jarolim, E; Prassl, R; Mangge, H.
Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.
Mol Pharm. 2013; 10(1):175-186 Doi: 10.1021/mp300316n [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Leading authors Med Uni Graz: Almer Gunter; Mangge Harald
Co-authors Med Uni Graz: Prassl Ruth
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Atherosclerosis (AS) causes cardiovascular disease, which leads to fatal clinical end points like myocardial infarction or stroke, the most prevalent causes of death in developed countries. An early, noninvasive method of detection and diagnosis of atherosclerotic lesions is necessary to prevent and treat these clinical end points. Working toward this goal, we examined recombinant interleukin-10 (IL-10), stealth liposomes with nanocargo potency for NMRI relevant contrast agents, and IL-10 coupled to stealth liposomes in an ApoE-deficient mouse model using confocal laser-scanning microscopy (CLSM). Through ex vivo incubation and imaging with CLSM, we showed that fluorescently labeled IL-10 is internalized by AS plaques, and a low signal is detected in both the less injured aortic surfaces and the arteries of wild-type mice. In vivo experiments included intravenous injections of (i) fluorescent IL-10, (ii) IL-10 targeted carboxyfluorescin (CF-) labeled stealth liposomes, and (iii) untargeted CF-labeled stealth liposomes. Twenty-four hours after injection the arteries were dissected and imaged ex vivo. Compared to free IL-10, we observed a markedly stronger fluorescence intensity with IL-10 targeted liposomes at AS plaque regions. Moreover, untargeted CF-labeled liposomes showed only weak, unspecific binding. Neither free IL-10 nor IL-10 targeted liposomes showed significant immune reaction when injected into wild-type mice. Thus, the combined use of specific anti-inflammatory proteins, high payloads of contrast agents, and liposome particles should enable current imaging techniques to better recognize and visualize AS plaques for research and prospective therapeutic strategies.
Find related publications in this database (using NLM MeSH Indexing): Animals -; Anti-Inflammatory Agents - metabolism; Apolipoproteins E - metabolism; Arteries - metabolism; Atherosclerosis - diagnosis Atherosclerosis - metabolism; Biological Markers - metabolism; Contrast Media - administration & dosage Contrast Media - chemistry; Cytokines - metabolism; Drug Delivery Systems -; Female -; Interleukin-10 - metabolism; Liposomes - administration & dosage Liposomes - chemistry Liposomes - pharmacokinetics; Magnetic Resonance Imaging - methods; Mice -; Mice, Inbred BALB C -; Microscopy, Confocal - methods; Plaque, Atherosclerotic - diagnosis Plaque, Atherosclerotic - metabolism; Polyethylene Glycols - administration & dosage Polyethylene Glycols - chemistry; Recombinant Fusion Proteins - administration & dosage; Spleen - drug effects Spleen - metabolism
Find related publications in this database (Keywords): IL-10; liposomes; atherosclerosis; inflammation; imaging